Neovacs SA ALNEV.PA

‎€‎0.00190(-13.64%)(1D)

• Delayed prices by Euronext • in EUR

Invest in Neovacs SA
Today

Create an eToro account to buy ALNEV.PA stock on a secure, user-friendly, multi-asset trading platform.

Neovacs SA ALNEV.PA

Buy ALNEV.PA

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Commercial Intl Bank-Gdr Reg

Moneysupermarket.com Group PLC

147.67‎p‎

-2.57%

MAX

*Past performance is not an indication of future results

Jump to:

About ALNEV.PA >
How to Buy? >
Top Guides >

The Neovacs SA share price is on the decline this week.

The Neovacs SA share price today is ‎€‎0.0019, reflecting a ‎-13.64‎% change over the last 24 hours and ‎-34.48‎% over the past week. The current market capitalization of ALNEV.PA is ‎€‎1000 with an average volume in the last three months of 7.1M. The stock has a P/E ratio of 0 and a dividend yield of 0%. With the stock’s beta sitting at -205.82

Why invest in stocks on eToro?

Start with ‎$‎50

Low fees

users worldwide

Across 70+ countries

Get Started

ALNEV.PA Key Metrics

Market Cap

‎€‎1000

Day’s Range

‎€‎0.0018 - ‎€‎0.002

52W Range

‎€‎0.0018 - ‎€‎6000

Average Volume (3M)

7.1M

Price-Earnings Ratio

Revenue

‎€‎131778

Dividend (Yield)

‎€‎0 (0%)

Prev Close

‎€‎0.0019

EPS

‎€‎-11026.65

Beta

-205.82

How can I buy Neovacs SA stocks?

To purchase Neovacs SA:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Neovacs SA (ALNEV.PA) page and place an order to buy Neovacs SA.

Buy ALNEV.PA

Looking for more information? Check out our guide on Academy.

What Is Neovacs SA?

Neovacs SA develops and invests in immunotherapy solutions that target autoimmune and inflammatory diseases. Based in France, the company aims to develop its own treatments and invest in innovative biotech and medtech companies.

Operating within the healthcare sector, Neovacs SA originated as a spin-off of Paris Sorbonne. It specialises in the development of Kinoid therapeutic vaccines, which help the body to induce a sustained immune response. Its lead clinical products aim to treat lupus and allergies.

Track the share price of ALNEV.PA by adding it to your eToro watchlist.

CEO

Hugo Brugière

Employees

Founded

1992

Suresnes, Ile-de-France, FR

Med Tech

Paris

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Neovacs SA
Today

Create an eToro account to buy ALNEV.PA stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Neovacs SA stock?

The current price of ALNEV.PA is ‎€‎0.0019.

What are analysts’ forecasts for Neovacs SA?

Analysts offer forecasts for Neovacs SA based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Neovacs SA?

The market capitalisation of Neovacs SA is ‎€‎1000

Daily Movers

Explore the biggest stocks movers on the market.